Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction

PHASE3CompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

September 30, 2010

Study Completion Date

March 31, 2011

Conditions
Knee Injuries
Interventions
DRUG

OMS103HP

Maximum of 39 liters of OMS103HP irrigation solution over a maximum of 2 hours.

DRUG

Vehicle

Maximum of 39 liters of vehicle irrigation solution over a maximum of 2 hours

Trial Locations (20)

15203

University of Pittsburgh Medical Center, Pittsburgh

16602

University Orthopedics Center, Altoona

16801

University Orthopedics Center, State College

23708

Naval Medical Center - Portsmouth, Portsmouth

30350

Southeastern Center for Clinical Trials, Atlanta

32607

University of Florida, Gainesville

43221

Ohio State University, Columbus

55454

Minnesota Sports Medicine, Minneapolis

78217

Unlimited Research, San Antonio

78666

Hill Country Sports Medicine, San Marcos

78681

Round Rock Orthopedics, Round Rock

78759

Texas Orthopedics, Austin

80110

Colorado Orthopedic Consultants, PC, Englewood

80487

American Clinical Research Services, Steamboat Springs

92024

CORE Orthopaedic Medical Center, Encinitas

94063

Sports, Orthopedic and Rehabilitation Medicine Associates (S.O.A.R.), Redwood City

94305

Stanford University, Stanford

98431

Madigan Army Medical Center, Tacoma

L1S 2J5

Rouge Valley Health Systems, Ajax

N9A 1E1

Hotel Dieu Grace Hospital, Windsor

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Omeros Corporation

INDUSTRY